REGISTERED CHARITY NUMBER: 800952
REPORT OF THE TRUSTEES AND
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
FOR
THE KIDNEY FUND
GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW

THE KIDNEY FUND
CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Report of the Trustees
Independent Examiner's Report
Statement of Financial Activities
Balance Sheet
Notes to the Financial Statements
Detailed Statement of Financial Activities
Page
1 to 2
3
4
5
6 to 11
12

THE KIDNEY FUND
REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 MARCH 2025
The trustees present their report with the financial statements of the charity for the year ended
31 March 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities:
Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the
Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January
OBJECTIVES AND ACTIVITIES
Objectives and aims
The Charity ("the Fund") is constituted by a Trust Deed and was established to build a Research Institute and
to promote research into renal failure and diabetes. A two- storey purpose built laboratory block was
completed in 1997 and in March 1998, Lord Rogers formally opened the South West Thames Institute for
Renal Research ("the SWTIRR") which is incorporated as an independent company limited by guarantee.
Money continues to be needed to fund the ongoing research of the SWTIRR and to publish useful results for
the benefit of renal patients. Grants are given regularly by the Fund to SWTIRR. The promotion of research
into renal failure and diabetes continues to be the key objective of the Fund.
Significant activities
The Fund has continued its main activity of supporting the South West Thames Institute of Renal Research
(SWTIRR). During the year 2024-2025, The Kidney fund provided a core grant of £147,407 to support the
work of SWTIRR, and £92,712 to the Kings College, to enable one of its students to undertake research. This
research project will be undertaken over a three year period and the Kidney Fund 's contribution for this
Project will be totalled over £275,000.
The income from various fundraising activities contributed £37,486 compared to £32,156 raised in the year
2023-2024. The Trustees are most grateful to those who have worked hard in difficult circumstances to
organise fundraising events and we value the time, energy, and efforts they have put in to raise funds for the
Charity During the year, the Fund received three legacies totalling £126,116. Our thanks are due to these
individuals who have remembered the Charity in their wills and to individual donors who had contributed to our
funds during the year. The Board, specifically, wishes, to record its gratitude to our Treasurer, Mr Gopal
Hooper who passed away In February this year. Mr Hooper had helped the Kidney Fund to maintain effective
governance of its activities and assisted and advised the Board on the direction of the Fund's strategy with
particular regard to ensuring the Charity's continued financial viability.
Public benefit
The Kidney Fund provides public benefit as a charity by:
o Supporting research into the nature, causes, diagnosis and treatment of renal failure and diabetes.
o Raising awareness and advancing public education in all areas relating to kidney disease.
The trustees have considered the Charity Commission's general guidance on public benefit and have taken it
into account when reviewing The Charity's aims and objectives and in planning its future activities. The
Trustees are satisfied that the aims of The Charity are carried out wholly in pursuit of its charitable aims for
the public benefit.
Financial position
The accounts of the year show a deficit on unrestricted funds of £3,876 and total unrestricted fund carried
forward at 31 March 2025 of £596,938. Restricted Funds at the year end totalled £42,261
The Trustees consider that the assets of the funds as disclosed in the financial statements are adequate to
enable it to continue to fulfil its obligations. The Trustees are committed to continue to explore ways to raise
additional funds to fulfil its obligations to support SWTIRR in its internationally recognised research work.
Page 1

THE KIDNEY FUND
REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 MARCH 2025
STRUCTURE, GOVERNANCE AND MANAGEMENT
The charity is controlled by its governing document, a deed of trust, and constitutes an unincorporated
charity. The Board of Trustees operated during the year with seven members. Meetings have been held on
Zoom to direct, oversee and assess the administration of the charity and consider opportunities for fund
raising. All trustees give of their time freely and no trustee remuneration was paid in the year. Day to day
administration of the Kidney Fund is being carried out by a part time Administrator.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
800952
Principal address
The Renal Unit
St Helier Hospital
Wrythe Lane
Carshalton
Surrey
SM5 1AA
Trustees
Dr MR Bending
Miss A Abena-Amoako
Dr D Makanjuola
C Howard
N Ford
G Hooper (deceased 2/2/25)
C Feasby (appointed 19/2/25)
CJ Moorhouse (appointed 3/7124)
Independent Examiner
Jonathan Hillier FCCA ACA
GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH16RW
Stockbrokers
JM Finn & Co
4 Coleman Street
London
EC2R 5TA
Approved by order of the board of trustees on
22M octebe 5 2025 and signed on its behalf by:
Page 2

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
THE KIDNEY FUND
Independent examiner's report to the trustees of The Kidney Fund
I report to the charity trustees on my examination of the accounts of The Kidney Fund (the Trust) for the year
ended 31 March 2025.
Responsibilities and basis of report
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with
the requirements of the Charities Act 2011 ('the Act).
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in
carrying out my examination I have followed all applicable Directions given by the Charity Commission under
Section 145(5)(b) of the Act.
Independent examiner's statement
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I
can confirm that I am qualified to undertake the examination because l am a member of the Institute of
Chartered Accountants in England and Wales, which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection
with the examination giving me cause to believe that in any material respect:
1.
2.
3.
accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
the accounts do not accord with those records; or
do not comply with the applicable requirements concerning the form and content of
accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement
that the accounts give a true and fair view which is not a matter considered as part of an independent
examination.
I have no concerns and have come across no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the accounts to be
reached.
Jonathan Hillier FCCA ACA
GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW
Date: 22/10/2025
Page 3

THE KIDNEY FUND
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 MARCH 2025
Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
Other trading activities
Investment income
Total
EXPENDITURE ON
Raising funds
Raising donations and legacies
Investment management costs
Unrestricted
funds
248,577
37,485
10,675
296,737
Restricted
fund
€
:
4
5
52,035
1,410
53,445
:
Charitable activities
SWITTR
Z Baalawy Kings College
Total
Net gains/(losses) on investments
NET INCOME/(EXPENDITURE)
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
147,407
92,712
293,564
(7,049)
(3,876)
:
-
600,814
596,938
42,261
42,261
The notes form part of these financial statements
Page 4
2025
Total
funds
€
248,577
37,485
10,675
296,737
52,035
1,410
53,445
147,407
92,712
293,564
(7,049)
(3,876)
643,075
639,199
2024
Total
funds
€
352,821
32,159
11,397
396,377
35,458
1,375
36,833
173,715
86,041
296,589
(5,022)
94,766
548,309
643,075

THE KIDNEY FUND
BALANCE SHEET
31 MARCH 2025
FIXED ASSETS
Social investments
CURRENT ASSETS
Debtors
Cash at bank and in hand
Notes
8
9
Unrestricted
funds
144,876
92,845
457,901
550,746
550,746
Restricted
-
42,261
42,261
42,261
2025
Total
funds
144,876
92,845
500,162
593,007
593,007
2024
Total
funds
153,540
23,471
470,324
493,795
493,795
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
ACCRUALS AND DEFERRED INCOME
10
NET ASSETS
FUNDS
Unrestricted funds
Restricted funds
TOTAL FUNDS
11
695,622
(98,684)
596,938
42,261
-
42,261
737,883
(98,684)
639,199
596,938
42,261
639,199
647,335
(4,260)
643,075
600,814
42,261
643,075
The financial statements were approved by the Board of Trustees and authorised for issue on
22nikEütöbü.and were signed on its behalf by:
2025.
dJ Moorhouse Trustee
The notes form part of these financial statements
Page 5

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
1.
ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been
prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities:
Statement of Recommended Practice applicable to charities preparing their accounts in accordance
with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)
(effective 1 January 2019), Financial Reporting Standard 102 'The Financial Reporting Standard
applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have
been prepared under the historical cost convention, as modified by the revaluation of certain assets.
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the
funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation
committing the charity to that expenditure, it is probable that a transfer of economic benefits will be
required in settlement and the amount of the obligation can be measured reliably. Expenditure is
accounted for on an accruals basis and has been classified under headings that aggregate all cost
related to the category. Where costs cannot be directly attributed to particular headings they have been
Grants offered subject to conditions which have not been met at the year end date are noted as a
commitment but not accrued as expenditure.
Social investments
Social investments are form of financial instrument and are initially recognised at their transactions
cost and subsequently measured at fair vale at the Balance sheet date, unless the value cannot be
measured reliably in which case it is measured at cost less impairment. Investment gains and losses
Statement of financial activities.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
trustees.
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the
estricted funds can only be used for particular restricted purposes within the objects of the char
estrictions arise when specified by the donor or when funds are raised for particular restrict
purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial
statements.
Page 6
continued..

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025
2.
4.
OTHER TRADING ACTIVITIES
Fundraising events
INVESTMENT INCOME
Other fixed asset invest - FlI
RAISING DONATIONS AND LEGACIES
Fundraising expenses
Support costs
2025
37,485
2025
10,675
2024
32,159
2024
11,397
2025
9,718
42,317
52,035
2024
10,375
25,083
35,458
5.
6.
7.
INVESTMENT MANAGEMENT COSTS
Portfolio management
2025
E
1,410
2024
1,375
TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the
year ended 31 March 2024
Trustees' expenses
There were no trustees' expenses paid for the year ended 31 March 2025 nor for the year ended
31 March 2024.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
Restricted
fund
Total
funds
INCOME AND ENDOWMENTS FROM
Donations and legacies
Other trading activities
Investment income
Total
352,821
32,159
11,397
396,377
:
352,821
32,159
11,397
396,377
EXPENDITURE ON
Raising funds
Raising donations and legacies
Investment management costs
35,458
1,375
36,833
-
Page 7
35,458
1,375
36,833
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
8.
Charitable activities
SWITTR
Z Baalawy Kings College
Total
Net gains/(losses) on investments
NET INCOME/(EXPENDITURE)
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
SOCIAL INVESTMENTS
172,794
86,041
295,668
(5,022)
95,687
921
921
(921)
505,127
600,814
43,182
42,261
MARKET VALUE
At 1 April 2024
Additions
Disposals
Revaluations
At 31 March 2025
NET BOOK VALUE
At 31 March 2025
At 31 March 2024
Page 8
Total
funds
173,715
86,041
296,589
(5,022)
94,766
548,309
643,075
Other
investments
€
153,540
4,099
(5,714)
(7,049)
144,876
144,876
153,540
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025
8.
SOCIAL INVESTMENTS - continued
Cost or valuation at 31 March 2025 is represented by:
Valuation in 2022
Valuation in 2023
Valuation in 2024
Valuation in 2025
Cost
9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Other debtors
Prepayments
10.
ACCRUALS AND DEFERRED INCOME
Accruals and deferred income
11.
MOVEMENT IN FUNDS
Unrestricted funds
General fund
Restricted funds
Restricted Fund
TOTAL FUNDS
At 1.4.24
€
600,814
42,261
643,075
Page 9
2025
92,608
237
92,845
2025
98,684
Net
movement
in funds
(3,876)
-
(3,876)
Other
investments
€
1,529
(12,444)
1,374
(7,049)
161,466
144,876
2024
23,152
319
23,471
2024
4,260
At
31.3.25
€
596,938
42,261
639,199
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025
11. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
Incoming
resources
Unrestricted funds
General fund
TOTAL FUNDS
296,737
296,737
Resources
expended
(293,564)
(293,564)
Comparatives for movement in funds
At 1.4.23
Unrestricted funds
General fund
Restricted funds
Restricted Fund
505,127
43,182
TOTAL FUNDS
548,309
Comparative net movement in funds, included in the above are as follows:
Incoming
resources
Unrestricted funds
General fund
Restricted funds
Restricted Fund
396,377
Resources
expended
€
(295,668)
-
(921)
TOTAL FUNDS
396,377
(296,589)
Page 10
Gains and
losses
€
(7,049)
(7,049)
Net
movement
in funds
95,687
(921)
94,766
Gains and
losses
(5,022)
-
(5,022)
Movement
in funds
(3,876)
(3,876)
At
31.3.24
600,814
42,261
643,075
Movement
in funds
95,687
(921)
94,766
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025
11.
MOVEMENT IN FUNDS - continued
A current year 12 months and prior year 12 months combined position is as follows:
At 1.4.23
Net
movement
in funds
At
31.3.25
Unrestricted funds
General fund
Restricted funds
Restricted Fund
505,127
91,811
596,938
43,182
(921)
42,261
TOTAL FUNDS
548,309
90,890
639,199
A current year 12 months and prior year 12 months combined net movement in funds, included in the
above are as follows:
Incoming
resources
Resource
expende
Gains and
losses
Movement
in funds
Unrestricted funds
General fund
Restricted funds
Restricted Fund
693,114
(589,232)
(12,071)
91,811
-
(921)
-
(921)
TOTAL FUNDS
693,114
(590,153)
(12,071)
90,890
12.
RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 March 2025.
Page 11

THE KIDNEY FUND
DETAILED STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 MARCH 2025
2025
INCOME AND ENDOWMENTS
Donations and legacies
Donations
Legacies
Other trading activities
Fundraising events
Investment income
Other fixed asset invest - FIl
Total incoming resources
EXPENDITURE
Raising donations and legacies
Fundraising expenses
Investment management costs
Portfolio management
Charitable activities
Grants to institutions
Support costs
Vanagemen
Administrative expense
Finance
Bank charges
Governance costs
Accountancy and legal fees
Total resources expended
Net income before gains and losses
Realised recognised gains and losses
Realised gains/(losses) on fixed asset
investments
Net (expenditure)/income
122,461
126,116
248,577
37,485
10,675
296,737
9,718
1,410
240,119
39,163
154
3,000
293,564
3,173
(7,049)
(3,876)
This page does not form part of the statutory financial statements
Page 12
2024
68,035
284,786
352,821
32,159
11,397
396,377
10,375
1,375
259,756
21,994
189
2,900
296,589
99,788
(5,022)
94,766